SCHEMBL20151671

SCHEMBL20151671

C#CC1(C)C=C(C)C(=O)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.38
CYP3A4 P08684 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CDC25B P30305 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
HPGD P15428 2/20 0.38
CDC25A P30304 2/20 0.38
PLIN1 O60240 1/20 0.38
NR1I2 O75469 1/20 0.38
USP2 O75604 1/20 0.38
GSR P00390 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166187 0.80 PGR (0.35) ALDH1A1MEN1KMT2APGR
SCHEMBL18166126 0.70 GPR84 (0.30) PGR
SCHEMBL4870136 0.67 IDO1 (0.38) IDO1CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL9861969 0.66 PDK2 (0.46)
SCHEMBL29522682 0.65 MEN1 (0.52) CYP3A4ALDH1A1MEN1KMT2ACDC25B
SCHEMBL12997894 0.65 MEN1 (0.52) CYP3A4ALDH1A1MEN1KMT2ACDC25B
SCHEMBL12997896 0.65 MEN1 (0.52) CYP3A4ALDH1A1MEN1KMT2ACDC25B
SCHEMBL1855552 0.65 MEN1 (0.52) CYP3A4ALDH1A1MEN1KMT2ACDC25B
SCHEMBL31638323 0.62 PGR (0.46) CYP3A4ALDH1A1MEN1KMT2ACDC25B
SCHEMBL28267013 0.62 PGR (0.46) CYP3A4ALDH1A1MEN1KMT2ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134654-A1 ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134654-A1 ACETYLENIC CYANOENONES AS THERAPEUTICS FOR INFLAMMATION AND CARCINOGENESIS ACOX3, ACOT7, ACOX1 IDO1 291/4885CYP3A4 1919/4885ALDH1A1 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.